JOGO Health

A breakthrough treatment for chronic pain & neuromuscular disorders

Print
Claim My Business
Categories
Technology, Financial Services, Service Businesses
Min Investment
$250
Location
Bridgewater, NJ
Expected Close Date
April 30, 2025
Target Raise
$500.00K-$3.00M
Security Price
$1.13
Website
jogohealth.com
Number of Employees
50
Cash
$2,447,570
Revenue
$274,267
Short Term Debt
$296,795
Cost of Goods
$0
Long Term Debt
$100,157
Net Income
$-2,529,678

Key Deal Facts

25,000+ patients treated across 50+ hospital channel partners
100,000+ patient sessions
Reimbursed by Medicare and commercial insurances
Backed by #1 Hospital in the World - Mayo Clinic, investor & co-development partner
Led by executives from IQVIA, AT&T, Johnson & Johnson, and Astrazeneca
20+ neuromuscular conditions (stroke, migraine, chronic pain, incontinence)
Co-founder with prior AI healthcare exit to #1 clinical research company IQVIA (10X return to invest
Patent protected with 18 claims

Management Team / Advisory Board Bios

Tier 1 VC-Backed
Raised $250K or more from a top-tier venture firm, Repeat Founder
Founder has started a previous company funded with $2M+, Dr. Gordon SilvermanEmeritus Product VisionaryEMG-BF pioneer. Inventor of E-ZPass. Built 1st iteration of JOGO with IBM. Author of foundational textbook “Cognitive Science”. 8 patents. Columbia University Engineering BS, BA, & MS. Polytechnic University Ph.D., Siva Nadarajah Co-Founder and PresidentHealthcare innovation exec. Built company from 0 to exit to IQVIA ($47B clinical research company). Part of the team that took IQVIA (formerly IMS Health) public. 3 healthcare AI patents. Electrical & Electronics Engineering BS., Sanjai Murali Founder and CEOClinical product visionary. Built card-based cash transaction system at AT&T, serving as the foundation of smart chips in credit and ATM cards globally. Built JOGO from 0 to FDA market authorization. Electrical Engineering BS. Computer Engineering MS., Gary Krasilovsky Chief Scientific OfficerPhysical therapy trailblazer. 40+ years in differential diagnosis & treatment in neurological rehabilitation. Educator of 1000+ physical therapy leaders at NYU, Ithaca College, & Hunter College. NYU Physical Therapy - Pathokinesiology MA & PhD., Jason KernenNational Sales DirectorAward-winning sales executive. Former Division Sales Manager at Astrazeneca. Ex-Account Manager at Johnson & Johnson & Jazz Pharmaceuticals. University of Delaware BA. Healthcare Administration MBA., Emily Cassata DPTClinical Program ManagerClinical healthcare pro. Develops products to streamline clinical operations & enhance patient experiences for telehealth & digital rehabilitation. Managed team of 40+ at VC-backed healthcare startup. Ex-Pfizer. Health Sciences BA. Physical Therapy DPT.
Amount Raised : $5,811,830
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter

0 Comments